April 5, 2019
Daiichi Sankyo said on April 4 that the European Medicines Agency (EMA) has accepted its cancer drug pexidartinib for approval review as a treatment for adult patients with symptomatic tenosynovial giant cell tumor (TGCT). The submission is based on data...read more